OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review

As we look ahead to 2026, we are continuing to execute on our strategy with purpose and momentum to create value for all our stakeholders.” OTI’s rapid self-test for CT/NG is built on the Sherlock ...
Zacks Investment Research on MSN

OraSure files for FDA review of molecular self-test & Colli-Pee device

OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...

OraSure seeking FDA approval for pair of products

The Bethlehem-based maker of at-home diagnostic tests said it submitted two separate applications to the FDA at the end of ...
Seeking Alpha

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

BETHLEHEM, Pa., June 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (OSUR), a global leader in point-of-care and at-home diagnostic testing, as well as non-invasive self-sampling technologies ...

OraSure Seeks FDA Clearance for New STI Tests

Detailed price information for Orasure Tech Inc (OSUR-Q) from The Globe and Mail including charting and trades.
technologynetworks

First-Void Urine: An Innovative Sample Type for HPV Screening

Urine analysis is a routine technique to identify and diagnose various health conditions. However, standard urine samples often fail to capture the full range of biomarkers present in the urine, as ...
Kaleido Scope

Dr. Askenazi awarded funding from the Harbert Institute for ZorroFlow project

David Askenazi M.D., MSPH, professor in the Division of Pediatric Nephrology, has received funding from the Bill L. Harbert Institute for Innovation and Entrepreneurship to support his project ...
TipRanks on MSN

OraSure submits CT/NG molecular self-test, Colli-Pee device for FDA review

Technologies submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration for clearance of its ...